The EANO website serves the neurooncology community by providing current research news on neurooncology topics, facilitating collaboration on research projects, advertising job opportunities, providing a discussion forum for members and disseminating information about relevant events.
EANO members can login to access the full website. If you're not a member, find out here how to become an EANO member.
GUIDELINES ON MANAGEMENT OF LOW GRADE GLIOMAS:
REPORT OF AN EFNS-EANO TASK FORCE
Riccardo Soffietti1, MD, Brigitta Baumert2, MD, Lorenzo Bello3, MD, Andreas von Deimling4, MD, Huges Duffau5, MD, Marc Frénay6, MD, Wolfgang Grisold7, MD, Robin Grant8, MD, Francesc Graus9, MD, Khe Hoang-Xuan10, MD, Martin Klein11, MD, Beatrice Melin12, MD, Jeremy Rees13, MD, Tali Siegal14, MD, Anja Smits15, MD, Roger Stupp16, MD, Wolfgang Wick17, MD.
1 Department of Neuroscience, University Hospital San Giovanni Battista, Turin, Italy
2 Dept. Radiation-Oncology (MAASTRO), Maastricht University Medical Center, The Netherlands
3 Department of Neurological Sciences, Neurosurgery, University, Milan, Italy
4 Department of Neuropathology, University, Heidelberg, Germany
5 Department of Neurosurgery, Hôpital Gui de Chauliac, Montpellier, France
6 Department of Medical Oncology, Centre Antoine Lacassagne, Nice, France
7 Department of Neurology, Kaiser Franz Josef Hospital, Vienna, Austria
8 Centre for Neuro-Oncology, Western General Hospital, Edinburgh, United Kingdom
9 Service of Neurology, Hospital Clinic, Barcelona, Spain
10 Service de Neurologie, Groupe Hospitalier Pitié-Salpêtrière, Paris, France
11 Department of Medical Psychology, VU University Medical Center, Amsterdam, The Netherlands
12 Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden
13 National Hospital for Neurology and Neurosurgery, London, United Kingdom
14 Center for Neuro-Oncology, Hadassah Hebrew University Hospital, Jerusalem, Israel
15 Department of Neuroscience, Neurology, University Hospital, Uppsala, Sweden
16 Department of Neurosurgery, Medical Oncology, University Hospital and University, Lausanne, Switzerland
Now available in the European Journal f Neurology, Volume 17, Issue 9, pages 1124–1133, September 2010 (http://onlinelibrary.wiley.com/doi/10.1111/j.1468-1331.2010.03151.x/abstract
multidisciplinary Symposium on "Neuro-Oncology in Eastern European and North African Countries"
During the EANO Meeting in Maastricht, on September 19, a multidisciplinary Symposium on "Neuro-Oncology in Eastern European and North African Countries" will take place.
The objective is to compare the organization of Neuro-Oncology in Western and non Western countries and establish future forms of cooperation.
Speakers from different countries and different professional will give an overview of the status of Neuro-Oncology in their respective countries. Particular attention will be paid to following issue: access to neurosurgical, radiotherapeutical and oncological facilities; access to conventional and advanced MRI/PET machines; standard treatment for major tumor types (gliomas, meningiomas, metastasis); multidisciplinary teams availability; research and training programs; development of a core curriculum in Neuro-Oncology. A round table discussion will close the event.
Riccardo Soffietti
Dept Neuro-Oncology
University and San Giovanni Battista Hospital
Torino, Italy
From our Swish Correspondent, Dr. Andreas F. Hottinger
Switzerland lies in the middle of Europe. Despite this (or because of this), we Swiss people have a tendency to do things very differently than the rest of Europe. Since last year, and thanks to (or because of) bevacizumab, this adage also applies in neurooncology. Bevacizumab is a monoclonal antibody against vascular endothelial growth factor.